The Biobased and Renewable Products Advocacy Group (BRAG) helps members develop and bring to market their innovative biobased and renewable chemical products through insightful policy and regulatory advocacy. BRAG is managed by B&C® Consortia Management, L.L.C., an affiliate of Bergeson & Campbell, P.C.
B&C And Sterne, Kessler, Goldstein & Fox P.L.L.C. Host Bioeconomy Leaders and Innovators Reception During BIO World Congress 2017
  • Email This
  • Print
  • Share Link

Scientists, executives, and investors gathered in Montreal, Canada on Tuesday evening for a fascinating and wide-ranging discussion on current issues facing bioeconomy leaders and innovators.  The reception, hosted by Bergeson & Campbell, P.C. (B&C®) and Sterne, Kessler, Goldstein & Fox P.L.L.C., included a brief question and answer (Q&A) session with Christine Lhulier, Corporate Counsel for DuPont Industrial Biosciences, Richard E. Engler, Ph.D., Senior Chemist with B&C, and Jeremiah B. Frueauf, Director in the Biotechnology/Chemical Group at Stern Kessler.  The panel discussed the variety of the incentives and challenges related to growing the bioeconomy, and fielded questions from many of the attendees. 
 
When asked what industries might be affected by the bioeconomy in 2040, Ms. Lhulier stated that she could not name an industry that would not be impacted by renewable resources in the future.  In response to the question “what should be the key driver in growing the bioeconomy?,” the panelists highlighted the need for clear regulatory policies that ensure parity for the commercialization of biobased and petroleum-based products, while recognizing the role that industry and academic institutions play in driving innovation.  It was also noted that global alignment on biobased policies and procedures, and the development of feedstock-agnostic technologies, would help to accelerate the growth of the bioeconomy. 
 
After a guest commented on the impact the negative public perception of biotechnology has on innovation, Dr. Engler pointed out the public’s poor understanding of biotechnology, its safety, and the extent to which it is utilized in the marketplace already.  Another attendee suggested that the biobased industry consider playing a role in informing the public of the benefits of biobased processes.  At the conclusion of the Q&A portion of the evening, many guests stayed to continue the conversation with the panelists and attendees.